病院・クリニック向けPRP治療・幹細胞治療・再生医療支援(サポート)サービス/細胞塊スフェロイド三次元培養マイクロプレート「TASCL」

TEL:050-7115-9215
451-0042
名古屋市西区那古野2-14-1 なごのキャンパス
E-mail:info@cymss-bio.com

Our Businesses

1. Cell cluster mass culture / differentiation induction microplate business

The need for cell clusters (3D culture of cells and spheroids) is increasing in regenerative medicine. Many researchers and culture engineers want to cultivate homogeneous cell mass easily in large quantities (3D culture). But I think there was no good way so far.

Cell cluster mass culture microplate "TASCL" (taskle) was developed by our original microfabrication technology and surface treatment technology. The feature is that a mass of cells with almost uniform shape and size can be cultured in large quantities at once, and differentiation can be induced by long-term culture for about one month. It is easy to use and allows microscopic observation of cells on TASCL. The total cost of equipment, media and reagents can be reduced.
 

2. Automatic cell culture equipment / screening equipment

The small-sized automatic cell culture device “Desk-Top CPC” using TASCL is an innovative device that can control cell culture automatically at a low cost. We plan to manufacture and sell in the near future.
We will also investigate the development of a system that can be used for drug discovery screening as it is after mass-culturing cell clusters with TASCL.
 

3. Cell cluster processing business

Using TASCL, we will manufacture and sell various cell clusters differentiated and cultured for research purposes. In the future, we plan to manufacture and sell these cell clusters as pharmaceuticals.

TASCL

Items
       
TASCL1000 well model    TASCL600 well model
 
TASCL Package
 
TASCL Flyer ⇒  TASCL商品チラシ
 
TASCL Manual ⇒ 使用方法
 
 
Cell cluster mass culture / differentiation induction microplate "TASCL" (taskle) was developed by our original fine processing technology and surface treatment technology. The feature is that large-scale cell clusters of almost uniform shape and size can be cultured at once, and differentiation can be induced by long-term culture for about one month. It is easy to use and allows microscopic observation of cells on TASCL. The total cost of equipment, media and reagents can be reduced.

 

                            
    Cell cluster culture with TASCL         Fluorescence detection of cell clusters on TASCL

 
 

<Seven features of TASCL>

(1) Mass culture of almost uniform cell clusters at a time (about 3600 / about 6000)
(2) The state of the cells can be kept long and good ... because the bottom surface penetrates and the gas and medium circulate
(3) Differentiation can be induced ... Long-term culture for one month is possible.
(4) Total cost can be reduced ... Small and dense well structure saves equipment, medium and reagents
⑤ Opened and ready to use ... Protein-prevented, sterilized, pre-equipped
⑥ Easy to use ... Seeding is done by simply seeding the cell suspension from above (no centrifugation required), and medium replacement is easy.
⑦Easy to observe ... Microscopic observation of cells can be done on TASCL
 
For more information about TASCL, please refer to “About TASCL”.

       
   

About Us

We are a bio-venture that deals with 3D cell cluster (spheroid) mass culture / differentiation induction and cell cluster treatment solutions based on the microfabrication technology and surface treatment technology of the University of Tokyo. Our company will work on the following businesses.
1) Regenerative medical device business
2) Cell cluster processing business
3) Cell cluster automatic culture business
4) Cell cluster analysis business
3D cell cluster (spheroid) mass culture / differentiation induction microplate "TASCL" is a product developed by our original microfabrication technology and surface treatment technology.
Our company was established on July 11, 2018, as a company responsible for cell cluster solutions based on TASCL. We hope that the products we offer will eventually spread to regenerative medicine research and clinical settings and contribute to the promotion of regenerative medicine in Japan and overseas.
 

 
Cymss-bio, Inc.,
CEO
Jun Kadowaki